Side Effects of Mirtazapine

Mirtazapine is an antidepressant medicine which is used to treat depression and sometimes Obsessive Compulsive Disorder and anxiety. It is used to improve a person’s mood and well-being. It works by restoring the balance of neurotransmitters in the brain. This is a prescription only medication which can come in either tablet or liquid form.

Mirtazapine, like all drugs, comes with potential risks and side effects. Potential side effects of Mirtazapine include: drowsiness, Lightheadedness; weight gain; increased appetited; dry mouth; constipation and dizziness. These side effects should be considered before prescribing Mirtazapine to a patient, taking into account the patient’s mental and physical history to decide whether the benefits would outweigh these potential side effects.

Potential medical conditions can increase the risk of side effects. For example, the risk of QT prolongation (a condition that affects heart rhythm) can be increased if you slow heartbeat, heart failure, a family history of certain heart problems such as sudden cardiac death. Low levels of potassium in the blood and the use of diuretics can also increase the risk of Mirtazapine. This reemphasises the importance of considering the history of the patient before prescribing Mirtazapine.

When prescribing Mirtazapine, a consultation should be held so as to discuss the potential side effects with the patient. If the patient has any follow up questions regarding the side effects of Mirtazapine, or the usage, then they can arrange a follow up appointment with the GP in question so as to discuss this in more detail, in order to ensure that the patient is comfortable with their prescription.

THEMIS Stand BOA 2025

THEMIS at the British Orthopaedic Association Conference 2025

This week, the THEMIS team had the pleasure of attending the British Orthopaedic Association (BOA) Conference in Liverpool, and it was an inspiring few days for everyone involved.

Read More
THEMIS Stand

THEMIS at the RCOG World Congress 2025

We’ve partnered with the RCOG on a number of occasions, and this event gave us another brilliant opportunity to reaffirm our long-term commitment to supporting those working in this discipline.

Read More
Themis Representative Meeting

THEMIS and QBE Forge Strategic Partnership to Shape the Future of Medical Malpractice Indemnity

THEMIS is pleased to announce a five-year capacity agreement with QBE, one of the world’s leading insurers. This partnership reflects a shared commitment to providing the healthcare sector with a stable, robust, and future-focused indemnity solution.

Read More